EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

39 hedge funds and large institutions have $68.5M invested in Eiger BioPharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
39
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.92M
2
+$977K
3
+$741K
4
Renaissance Technologies
Renaissance Technologies
New York
+$660K
5
BlackRock
BlackRock
New York
+$513K

Top Sellers

1
-$5.36M
2
-$4.18M
3
-$2.09M
4
PM
Prosight Management
Texas
-$1.46M
5
EAM
Eventide Asset Management
Massachusetts
-$611K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$191K
27
$180K
28
$158K
29
$147K
30
$122K
31
$116K
32
$99K
33
$37K
34
$16K
35
$5K
36
$2K
37
$1K
38
$621
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
1
2